# New clinical trials in Honduras: 34 since Nov 2024

Updated October 7, 2026.

34 clinical studies with a site in Honduras were first posted on ClinicalTrials.gov from November 26, 2024 to October 7, 2026; 16 have an industry sponsor and 18 are recruiting or about to. The newest, NCT07863960, was posted on October 7, 2026: Efficacy and Safety of Photobiomodulation for Postoperative Pain After Cesarean Section (Universidad Nacional Autonoma de Honduras).

## The full list

New clinical trials with a site in Honduras: 34 rows for $5, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/country/honduras

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 34
- Industry sponsored: 16
- Recruiting or not yet: 18
- Latest posted: October 7, 2026

## Newest trials

The newest 34 of 34, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 7, 2026 | NCT07863960 | Efficacy and Safety of Photobiomodulation for Postoperative Pain After Cesarean Section | Universidad Nacional Autonoma de Honduras | Not applicable | Recruiting | Postoperative Pain After Cesarean Section | 210 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07863960) |
| September 23, 2026 | NCT07836855 | A Fellow Eye Comparative Study of the Aquea Intracanalicular Glaucoma Micro-coil Stent and the Alcon Hydrus Glaucoma Microstent | Aquea Health, Inc. | Not applicable | Completed | Cataract Senile, Glaucoma, Open Angle | 16 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07836855) |
| June 22, 2026 | NCT07661316 | Combination Therapies for Trichuris Trichiura Infection in Schoolchildren in Honduras | Mundo Sano Foundation | Phase 3 | Not yet recruiting | Trichuriasis, Strongyloidiasis, Ascariasis, Hookworm Infection, Soil-Transmitted Helminthiasis | 368 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07661316) |
| June 15, 2026 | NCT07648251 | Furosemide vs Placebo in Severe Preeclampsia Postpartum | Universidad Nacional Autonoma de Honduras | Phase 2 | Not yet recruiting | Severe Preeclampsia | 186 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07648251) |
| June 8, 2026 | NCT07632014 | CAYA Cancer Prospective Cohort Study | Resonance, Inc. | Observational | Recruiting | Cancer, Pediatric Cancer, Lymphoblastic Lymphoma (LBL), Acute Lymphoblastic Leukemia (ALL) | 6,000 | Armenia, Egypt, El Salvador, Guatemala, Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07632014) |
| April 22, 2026 | NCT07544420 | aKLmRNA-mediated Protein Replacement Therapy | Klothea Bio Inc | Phase 1 | Not yet recruiting | Aging | 21 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07544420) |
| March 2, 2026 | NCT07443826 | CALM-AF-AI: Counteracting Age-related Loss of Muscle With AAV-Follistatin Combined With Angiogenesis-Inducing VEGF Plasmid Gene Therapy | Unlimited Biotechnology LLC | Phase 1/2 | Recruiting | Age-related Muscle Decline | 12 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07443826) |
| February 27, 2026 | NCT07440069 | Analgesic Efficacy and Obstetric Effects of Tramadol, Paracetamol and Placebo in Active Labor | Universidad Nacional Autonoma de Honduras | Phase 4 | Recruiting | Labor Pain | 300 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07440069) |
| February 23, 2026 | NCT07428317 | Use of Lubricant Gel to Shorten the Second Stage of Labor During Vaginal Delivery | Universidad Nacional Autonoma de Honduras | Not applicable | Recruiting | Prolonged Second Stage of Labor | 160 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07428317) |
| February 18, 2026 | NCT07418151 | Effect of Maternal Chocolate Consumption on Fetal Non-Stress Test (NST) Reactivity. | Universidad Nacional Autonoma de Honduras | Not applicable | Recruiting | Fetal Distress | 190 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07418151) |
| February 17, 2026 | NCT07415252 | SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years | SK Bioscience Co., Ltd. | Phase 3 | Recruiting | Varicella (Chickenpox) | 780 | Honduras, Philippines, South Korea, Thailand | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07415252) |
| February 13, 2026 | NCT07411352 | Left Lateral Position vs Supine Position to Reduce Active Labor Duration | Universidad Nacional Autonoma de Honduras | Not applicable | Recruiting | Labor Pain | 188 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07411352) |
| February 10, 2026 | NCT07401160 | Umbilical Cord Drainage to Prevent Postpartum Hemorrhage | Universidad Nacional Autonoma de Honduras | Not applicable | Recruiting | Postpartum Hemorrhage | 400 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07401160) |
| February 10, 2026 | NCT07401147 | Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Management During Labor. | Ricardo A Gutierrez Ramirez, MD, MSc, FACOG | Not applicable | Recruiting | Labor Pain | 132 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07401147) |
| January 16, 2026 | NCT07348692 | Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age | Sanofi | Phase 3 | Recruiting | Pneumococcal Immunization, Healthy Volunteers | 2,195 | Honduras, Puerto Rico, Thailand, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07348692) |
| December 16, 2025 | NCT07285629 | Safety and Efficacy of Klotho and Follistatin Gene Therapy | Minicircle | Early phase 1 | Completed | Healthy Adults | 14 | Honduras, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07285629) |
| November 24, 2025 | NCT07246213 | CAYA Cancer Retrospective Cohort Study | Resonance, Inc. | Observational | Recruiting | Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Young Adult Cancer, Adolescent Cancer, Childhood Cancers, Acute... | 18,000 | Armenia, Egypt, El Salvador, Guatemala, Honduras, Tanzania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07246213) |
| November 18, 2025 | NCT07232355 | Prevention of Cervical Cancer Using the Genotyping Screening and Same-day Self-sampling | Atila Biosystems Inc. | Observational | Recruiting | Human Papilloma Virus | 5,000 | El Salvador, Honduras, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07232355) |
| October 15, 2025 | NCT07216781 | Safety and Efficacy of Injectable Klotho Plasmid Gene Therapy in Humans | Minicircle | Phase 1 | Active not recruiting | Healthy Adults | 14 | Honduras, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07216781) |
| September 4, 2025 | NCT07154810 | Observational Study to Evaluate Long Term Outcomes for Ocular Hypertension and Glaucoma Patients Treated With the SpyGlass Bimatoprost... | SpyGlass Pharma, Inc. | Observational | Active not recruiting | Glaucoma, Cataract, Ocular Hypertension | 23 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07154810) |
| September 4, 2025 | NCT07154797 | Evaluation of the Safety and Effectiveness of the Bimatoprost Implant System / IOL Combination in Patients With Ocular Hypertension or Mild... | SpyGlass Pharma, Inc. | Not applicable | Completed | Cataract, Ocular Hypertension, Glaucoma | 24 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07154797) |
| August 5, 2025 | NCT07103148 | A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population | Sanofi | Phase 3 | Active not recruiting | Yellow Fever Immunization | 2,440 | Honduras, Mexico, Panama | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07103148) |
| June 6, 2025 | NCT07009236 | A Study Evaluating the Safety and Efficacy of MINIject S+ in Subjects With Open Angle Glaucoma | iSTAR Medical | Not applicable | Recruiting | Glaucoma | 60 | Honduras, United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07009236) |
| February 13, 2025 | NCT06824194 | Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age | Sanofi | Phase 3 | Active not recruiting | Pneumococcal Immunization | 2,360 | Honduras, Mexico, Puerto Rico, Thailand, Turkey (Türkiye), United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06824194) |
| February 6, 2025 | NCT06811584 | Peanut Ball in Labor to Reduce Anxiety and Pain | Ricardo A Gutierrez Ramirez, MD, MSc, FACOG | Not applicable | Completed | Labor Stage, First, Anxiety, Pain Intensity Assessment | 163 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06811584) |
| February 5, 2025 | NCT06809985 | Latent Phase Membrane Stripping for Caesarean Section Reduction | Ricardo A Gutierrez Ramirez, MD, MSc, FACOG | Not applicable | Completed | Cesarean Delivery, Cervical Ripening, Latent Phase Labour | 71 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06809985) |
| February 3, 2025 | NCT06806137 | A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3... | GlaxoSmithKline | Phase 3 | Recruiting | Chickenpox | 600 | Dominican Republic, Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06806137) |
| January 22, 2025 | NCT06788132 | Cranberry, Hibiscus, and Vitamin C Extracts Versus Placebo in Latency of Premature Rupture of Membranes. | Ricardo A Gutierrez Ramirez, MD, MSc, FACOG | Not applicable | Completed | Premature Rupture of Membranes, Fetal Complications | 84 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06788132) |
| January 20, 2025 | NCT06784024 | Topical Lidocaine vs. Traditional Management in Manual Vacuum Aspiration Pain Management. | Ricardo A Gutierrez Ramirez, MD, MSc, FACOG | Not applicable | Completed | Endometrial Hyperplasia, Endometrial Diseases | 129 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06784024) |
| January 8, 2025 | NCT06763484 | Paroxetine Versus Placebo for Vasomotor Symptom Management in Surgical Menopause | Universidad Nacional Autonoma de Honduras | Phase 2 | Completed | Menopause Syndrome, Menopause Surgical, Hot Flashes | 90 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06763484) |
| January 6, 2025 | NCT06760026 | Cosmetic Results With Tissue Adhesive vs. Subdermal Sutures in Cesarean Section | Ricardo A Gutierrez Ramirez, MD, MSc, FACOG | Not applicable | Completed | Cesarean Wound Repair, Cesarean Section Scar, Cosmetic Appearance of Cesarean Scar, Tissue Adhesives | 36 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06760026) |
| January 6, 2025 | NCT06759350 | Soy Isoflavonates Versus Placebo on Quality of Life in Menopausal Women | Universidad Nacional Autonoma de Honduras | Not applicable | Completed | Menopause, Menopausal Women, Soy Isoflavone Effect, Quality of Life | 100 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06759350) |
| December 16, 2024 | NCT06736041 | Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age | Sanofi Pasteur, a Sanofi Company | Phase 3 | Active not recruiting | Pneumococcal Immunization | 1,714 | Australia, Honduras, Puerto Rico, South Korea, Thailand, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06736041) |
| November 26, 2024 | NCT06705140 | A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers | Sanofi Pasteur, a Sanofi Company | Phase 3 | Terminated | RSV Immunisation, Healthy Volunteers | 42 | Honduras | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06705140) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| Universidad Nacional Autonoma de Honduras | 9 | October 7, 2026 |
| Ricardo A Gutierrez Ramirez, MD, MSc, FACOG | 6 | February 10, 2026 |
| Sanofi | 3 | January 16, 2026 |
| Resonance, Inc. | 2 | June 8, 2026 |
| Minicircle | 2 | December 16, 2025 |
| SpyGlass Pharma, Inc. | 2 | September 4, 2025 |
| Sanofi Pasteur, a Sanofi Company | 2 | December 16, 2024 |
| Aquea Health, Inc. | 1 | September 23, 2026 |
| Mundo Sano Foundation | 1 | June 22, 2026 |
| Klothea Bio Inc | 1 | April 22, 2026 |
| Unlimited Biotechnology LLC | 1 | March 2, 2026 |
| SK Bioscience Co., Ltd. | 1 | February 17, 2026 |
| Atila Biosystems Inc. | 1 | November 18, 2025 |
| iSTAR Medical | 1 | June 6, 2025 |
| GlaxoSmithKline | 1 | February 3, 2025 |

## Conditions

| Condition group | New trials | Latest |
| --- | --- | --- |
| Labor Pain | 3 | February 27, 2026 |
| [Glaucoma](https://specstream.ai/data/clinical-trials/condition/glaucoma) | 3 | September 4, 2025 |
| [Neoplasms](https://specstream.ai/data/clinical-trials/condition/neoplasms) | 2 | June 8, 2026 |
| [Precursor Cell Lymphoblastic Leukemia-Lymphoma](https://specstream.ai/data/clinical-trials/condition/precursor-cell-lymphoblastic-leukemia-lymphoma) | 2 | June 8, 2026 |
| Chickenpox | 2 | February 17, 2026 |
| [Agnosia](https://specstream.ai/data/clinical-trials/condition/agnosia) | 2 | February 10, 2026 |
| [Cataract](https://specstream.ai/data/clinical-trials/condition/cataract) | 2 | September 4, 2025 |
| Ocular Hypertension | 2 | September 4, 2025 |
| Glaucoma, Open-Angle | 1 | September 23, 2026 |
| Trichuriasis | 1 | June 22, 2026 |
| Strongyloidiasis | 1 | June 22, 2026 |
| Ascariasis | 1 | June 22, 2026 |
| Hookworm Infections | 1 | June 22, 2026 |
| [Pre-Eclampsia](https://specstream.ai/data/clinical-trials/condition/pre-eclampsia) | 1 | June 15, 2026 |
| [Hypertension](https://specstream.ai/data/clinical-trials/condition/hypertension) | 1 | June 15, 2026 |
| [Sarcopenia](https://specstream.ai/data/clinical-trials/condition/sarcopenia) | 1 | March 2, 2026 |
| Muscular Atrophy | 1 | March 2, 2026 |
| Muscle Weakness | 1 | March 2, 2026 |
| [Frailty](https://specstream.ai/data/clinical-trials/condition/frailty) | 1 | March 2, 2026 |
| Fetal Distress | 1 | February 18, 2026 |
| Postpartum Hemorrhage | 1 | February 10, 2026 |
| Pneumococcal Infections | 1 | January 16, 2026 |
| Yellow Fever | 1 | August 5, 2025 |
| [Anxiety Disorders](https://specstream.ai/data/clinical-trials/condition/anxiety-disorders) | 1 | February 6, 2025 |
| Fetal Membranes, Premature Rupture | 1 | January 22, 2025 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 15 | October 7, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 8 | June 22, 2026 |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 4 | June 8, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 2 | June 15, 2026 |
| [Phase 1](https://specstream.ai/data/clinical-trials/phase/phase-1) | 2 | April 22, 2026 |
| [Phase 1/2](https://specstream.ai/data/clinical-trials/phase/phase-1-2) | 1 | March 2, 2026 |
| [Phase 4](https://specstream.ai/data/clinical-trials/phase/phase-4) | 1 | February 27, 2026 |
| [Early phase 1](https://specstream.ai/data/clinical-trials/phase/early-phase-1) | 1 | December 16, 2025 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).